DBV Technologies, creator of Viaskin, has entered into a collaboration agreement with BioNet-Asia and the University of Geneva (UNIGE) to work on a whooping cough (pertussis) booster vaccine. The clinical proof of concept product ...
Tags: DBV Technologies, Booster Vaccine
US-based research and development biotechnology firm Boston Strategics has entered into a new drug development partnership with Fujifilm Pharmaceuticals USA (FPHU), a global pharmaceutical development center of Japan's Fujifilm Corporation. ...
Tags: Oncology Drugs, Fujifilm Pharma
The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) first adjuvanted vaccine for the prevention of H5N1 influenza, also known as avian or bird flu. The pandemic Influenza A (H5N1) Virus Monovalent Vaccine, ...
Tags: Bird Flu Vaccine, GlaxoSmithKline
US-based Moderna Therapeutics has announced the completion of a new financing round, raising $110m to develop messenger RNA Therapeutics. In aggregate, Moderna has secured more than $415m in financing and partnerships to date from the ...
Israeli device manufacturer ITGI Medical announced a new partnership with Vascular Solutions. Under the new agreement, both companies will work together to land a Humanitarian Device Exemption (HDE) from FDA regulators for the ITGI ...
Viteava Pharmaceuticals has announced the execution of an exclusive worldwide license to an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, ...
Tags: exclusive worldwide license, EGCG, Viteava Pharmaceuticals
Innate Pharma has started a new program named IPH43, to develop an anti-MICA therapeutic antibody in oncology. The program is the newest to emerge from the company's discovery platform. MICA, which is highly polymorphic ligand of the NK ...
Tags: Innate Pharma, Anti-Mica Antibody
NanoViricides has secured orphan drug designation from the European Medicines Agency (EMA) for its drug candidate DengueCide, for the treatment of dengue and dengue hemorrhagic fever. Dengue fever is a mosquito-borne disease that affects ...
Tags: Nanoviricides Drug
Switzerland-based Helsinn group has granted Chugai Pharma Marketing, a wholly-owned subsidiary of Chugai Pharmaceutical, exclusive commercialization rights to their ghrelin receptor agonist, anamorelin, for the three major European pharma ...
Tags: Helsinn group, Pharma Marketing
Israeli bio-medical engineering company ITGI Medical has signed a strategic cooperation agreement with Vascular Solutions, a medical device company, to commercialize ITGI's Aneugraft Dx coronary covered stent in the US market. Pursuant to ...
Tags: ITGI Medical, Aneugraft DX Stent
Evotec has announced a collaboration with the Johnson & Johnson Innovation Center in California to identify new targets for Alzheimer's disease drug discovery and development. Under the terms of the agreement, Janssen Pharmaceuticals ...
Tags: Evotec, Johnson, innovation, Alzheimer
Cancer Research UK's commercial arm Cancer Research Technology (CRT) has collaborated with Danish drug discovery firm Nuevolution for the discovery of anti-cancer drug molecules targeting several key proteins. The deal is aimed at ...
Tags: Cancer Drugs, Medicine
Fidelity Biosciences, a subsidiary of Fidelity Investments, and US-based Regenx Biosciences have announced the formation of Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases. Dimension ...
Tags: Biosciences, Health, Medicine
AstraZeneca has selected an undisclosed oncology target from Regulus Therapeutics as part of their strategic alliance in order to discover, develop and commercialize microRNA therapeutics. Both the companies have entered into a strategic ...